Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic patients

被引:35
作者
Degirmenci, I [1 ]
Kebapci, N
Basaran, A
Efe, B
Gunes, HV
Akalin, A
Kurt, H
Urhan, M
Demirustu, C
机构
[1] Osmangazi Univ, Fac Med, Dept Med Biol, Eskisehir, Turkey
[2] Osmangazi Univ, Fac Med, Dept Endocrinol, Eskisehir, Turkey
[3] Mersin Univ, Fac Med, Dept Med Biol, Mersin, Turkey
[4] Osmangazi Univ, Fac Med, Dept Biostat, Eskisehir, Turkey
关键词
ACE gene polymorphism; nephropathy; PCR; type 2 diabetes mellitus;
D O I
10.1111/j.1368-5031.2005.00586.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We aimed to investigate the angiotensin-converting enzyme (ACE) gene polymorphism, ACE activity and their associations with diabetic complications in Turkish patients with type 2 diabetes mellitus. A total of 143 patients and 133 controls were screened for ACE gene I/D polymorphism by using polymerase chain reaction. Serum ACE activities were determined spectrophotometrically. There was no significant difference in the distribution of ACE I/D genotypes between patients and controls. The patients with DD genotype had a higher ACE activity than those with ID and II. Hypertensive diabetic patients with DD genotype had higher ACE activities than those with ID and II. There was no significant difference in the distribution of ACE I/D genotypes between patients with and without nephropathy, retinopathy and hypertension except for patients with and without neuropathy. In patients with DD genotype, creatinine clearance correlated with duration of diabetes. The grade of retinopathy was correlated with duration of diabetes in DD and ID genotypes. The highest ACE activity was measured in hypertensive diabetics with DD genotype. ID genotype was suggested to be a risk factor and II was suggested to be protective for diabetic neuropathy. The DD and ID genotypes might be a predictor for the development of retinopathy in relation to duration of diabetes.
引用
收藏
页码:1137 / 1142
页数:6
相关论文
共 33 条
[1]   ACE gene polymorphism in cardiovascular disease -: Meta-analyses of small and large studies in whites [J].
Agerholm-Larsen, B ;
Nordestgaard, BG ;
Tybjaerg-Hansen, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (02) :484-492
[2]   Deletion polymorphism at the angiotensin-converting enzyme gene in Turkish patients with coronary artery disease [J].
Akar, N ;
Aras, Ö ;
Ömürlü, K ;
Cin, S .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1998, 58 (06) :491-495
[3]  
Araz M, 2002, INT J CLIN PRACT, V56, P416
[4]   Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients [J].
Araz, M ;
Yilmaz, N ;
Güngör, K ;
Okan, V ;
Kepekci, Y ;
Aynacioglu, AS .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2001, 54 (02) :95-104
[5]  
BRAUNWALD E, 2001, PRINCIPLE INTERNAL M
[6]   PLASMA-LEVEL AND GENE POLYMORPHISM OF ANGIOTENSIN-CONVERTING ENZYME IN RELATION TO MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
COSTEROUSSE, O ;
TIRET, L ;
POIRIER, O ;
LECERF, L ;
GONZALES, MF ;
EVANS, A ;
ARVEILER, D ;
CAMBOU, JP ;
LUC, G ;
RAKOTOVAO, R ;
DUCIMETIERE, P ;
SOUBRIER, F ;
ALHENC-GELAS, F .
CIRCULATION, 1994, 90 (02) :669-676
[7]   Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with hypertension, non-insulin-dependent diabetes mellitus, and coronary heart disease in Taiwan [J].
Chuang, LM ;
Chiu, KC ;
Chiang, FT ;
Lee, KC ;
Wu, HP ;
Lin, BJ ;
Tai, TY .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (10) :1211-1214
[8]   ACE and PC-1 gene polymorphisms in normoalbuminuric Type 1 diabetic patients -: A 10-year prospective study [J].
de Azevedo, MJ ;
Dalmáz, CA ;
Caramori, MLA ;
Pecis, M ;
Esteves, JF ;
Maia, AL ;
Gross, JL .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2002, 16 (04) :255-262
[9]  
Doi Y, 1996, DIABETOLOGIA, V39, P97
[10]   Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: Risk of chronic renal failure [J].
Gumprecht, J ;
Zychma, MJ ;
Grzeszczak, W ;
Zukowska-Szczechowska, E .
KIDNEY INTERNATIONAL, 2000, 58 (02) :513-519